AAAAAA

   
Results: 1-10 |
Results: 10
TROPISETRON IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING OVER 6 COURSES OF EMETOGENIC CHEMOTHERAPY
Authors: BLEIBERG H HULSTAERT F BUYSE M DEKEYSER P
Citation: H. Bleiberg et al., TROPISETRON IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING OVER 6 COURSES OF EMETOGENIC CHEMOTHERAPY, Anti-cancer drugs, 9(9), 1998, pp. 773-777
TROPISETRON FOR TREATING ESTABLISHED POSTOPERATIVE NAUSEA AND VOMITING - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Authors: ALON E BUCHSER E HERRERA E CHRISTIAENS F DEPAUW C RITTER L HULSTAERT F GRIMAUDO V
Citation: E. Alon et al., TROPISETRON FOR TREATING ESTABLISHED POSTOPERATIVE NAUSEA AND VOMITING - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Anesthesia and analgesia, 86(3), 1998, pp. 617-623
SINGLE-DOSE IV TROPISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING AFTER GYNECOLOGICAL SURGERY
Authors: CAPOUET V DEPAUW C VERNET B IVENS D DERIJCKE V VERSICHELEN L VANAKEN H ICKX B RITTER L HULSTAERT F
Citation: V. Capouet et al., SINGLE-DOSE IV TROPISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING AFTER GYNECOLOGICAL SURGERY, British Journal of Anaesthesia, 76(1), 1996, pp. 54-60
CONTROL OF NAUSEA AND VOMITING BY NAVOBAN(R) (TROPISETRON) IN 131 CHILDREN RECEIVING CYTOTOXIC CHEMOTHERAPY
Authors: BENOIT Y HULSTAERT F VERMYLEN C SARIBAN E HOYOUX C UYTTEBROECK A OTTEN J LAUREYS G DEKERPEL I NORTIER D RITTER L DEKEYSER P
Citation: Y. Benoit et al., CONTROL OF NAUSEA AND VOMITING BY NAVOBAN(R) (TROPISETRON) IN 131 CHILDREN RECEIVING CYTOTOXIC CHEMOTHERAPY, Anti-cancer drugs, 6, 1995, pp. 9-14
OPTIMAL COMBINATION THERAPY WITH NAVOBAN(R) (TROPISETRON) IN PATIENTSWITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: VANBELLE SJP COCQUYT VFJ BLEIBERG H CANON JL BUYSE M HULSTAERT F DEWITTE M DEKEYSER P WESTELINCK K
Citation: Sjp. Vanbelle et al., OPTIMAL COMBINATION THERAPY WITH NAVOBAN(R) (TROPISETRON) IN PATIENTSWITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Anti-cancer drugs, 6, 1995, pp. 22-30
THE IMMUNE PROFILE OF MULTIPLE-SCLEROSIS - T-LYMPHOCYTE EFFECTS PREDOMINATE OVER ALL OTHER FACTORS IN CYCLOPHOSPHAMIDE-TREATED PATIENTS
Authors: STRAUSS K HULSTAERT F DENEYS V MAZZON AM HANNET I DEBRUYERE M REICHERT T SINDIC CJM
Citation: K. Strauss et al., THE IMMUNE PROFILE OF MULTIPLE-SCLEROSIS - T-LYMPHOCYTE EFFECTS PREDOMINATE OVER ALL OTHER FACTORS IN CYCLOPHOSPHAMIDE-TREATED PATIENTS, Journal of neuroimmunology, 63(2), 1995, pp. 133-142
TROPISETRON IN THE PREVENTION OF NAUSEA AND VOMITING IN 131 CHILDREN RECEIVING CYTOTOXIC CHEMOTHERAPY
Authors: BENOIT Y HULSTAERT F VERMYLEN C SARIBAN E HOYOUX C UYTTEBROECK A OTTEN J LAUREYS G DEKERPEL I NORTIER D RITTER L DEKEYSER P
Citation: Y. Benoit et al., TROPISETRON IN THE PREVENTION OF NAUSEA AND VOMITING IN 131 CHILDREN RECEIVING CYTOTOXIC CHEMOTHERAPY, Medical and pediatric oncology, 25(6), 1995, pp. 457-462
OPTIMAL COMBINATION THERAPY WITH TROPISETRON IN 445 PATIENTS WITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: HULSTAERT F VANBELLE S BLEIBERG H CANON JL DEWITTE M BUYSE M DEKEYSER P WESTELINCK KJ
Citation: F. Hulstaert et al., OPTIMAL COMBINATION THERAPY WITH TROPISETRON IN 445 PATIENTS WITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Journal of clinical oncology, 12(11), 1994, pp. 2439-2446
AN OPTIMIZED METHOD FOR ROUTINE HLA-B27 SCREENING USING FLOW-CYTOMETRY
Authors: HULSTAERT F ALBRECHT J HANNET I LANCASTER P BUCHNER L KUNZ J FALKENRODT A TONGIO M DEKEYSER F VEYS EM NOENS L MIR N COSTELLO C BECKER R STRAUSS K
Citation: F. Hulstaert et al., AN OPTIMIZED METHOD FOR ROUTINE HLA-B27 SCREENING USING FLOW-CYTOMETRY, Cytometry, 18(1), 1994, pp. 21-29
AGE-RELATED-CHANGES IN HUMAN BLOOD LYMPHOCYTE SUBPOPULATIONS .2. VARYING KINETICS OF PERCENTAGE AND ABSOLUTE COUNT MEASUREMENTS
Authors: HULSTAERT F HANNET I DENEYS V MUNHYESHULI V REICHERT T DEBRUYERE M STRAUSS K
Citation: F. Hulstaert et al., AGE-RELATED-CHANGES IN HUMAN BLOOD LYMPHOCYTE SUBPOPULATIONS .2. VARYING KINETICS OF PERCENTAGE AND ABSOLUTE COUNT MEASUREMENTS, Clinical immunology and immunopathology, 70(2), 1994, pp. 152-158
Risultati: 1-10 |